US12042527B2 | 23 July 2024 | Grant | US16736941 | Use of mrnas encoding ox40l, il-23 and il-36gamma in combination with immune checkpoint blockade for treating particular cancers | ModernaTX Inc |
---|
US12023371B2 | 2 July 2024 | Grant | US17127435 | Terminally modified rna | ModernaTX Inc |
---|
US11980672B2 | 14 May 2024 | Grant | US17844877 | Heterologous utr sequences for enhanced mrna expression | ModernaTX Inc |
---|
US11939601B2 | 26 March 2024 | Grant | US16765656 | Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria | ModernaTX Inc |
---|
US11918644B2 | 5 March 2024 | Grant | US17245973 | Varicella zoster virus (VZV) vaccine | ModernaTX Inc |
---|